Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Risk Factors Associated With Myelosuppression (Grade 4 Neutropenia) in Breast Cancer Patients Treated With Palbociclib in the Post-marketing Setting: Nested Case-control Study Using the Medical Information Database Network (MID-NET) Database

NCT05709158 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05709158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Risk Factors Associated With Myelosuppression (Grade 4 Neutropenia) in Breast Cancer Patients Treated With Palbociclib in the Post-marketing Setting: Nested Case-control Study Using the Medical Information Database Network (MID-NET) Database
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 19, 2024
Completion date
August 30, 2024
Enrollment
4,184 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer